Clinical Trial Update: Ipilimumab for Head and Neck Cancer Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating ipilimumab for squamous cell carcinoma of the head and neck is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Yervoy (ipilimumab)

Snippet

Sponsor: Providence Health & Services | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 1 | Status: ACTIVE_NOT_RECRUITING